DEVELOPMENT OF NOVEL DRUG PARTICLES FOR INHALATIONAL THERAPY
Award details are derived from public USAspending.gov records. Not a bid recommendation.
Award details
- Award ID
- HT942526FE005
- Contractor
- Awarding agency
- Department of Defense
- Sub-agency / office
- Defense Health Agency
- Award amount
- $140,595
- Period of performance
- Dec 3, 2025 – Dec 2, 2026
- NAICS
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- KS
- Parent award
- HT942524D0011
Public award description
DEVELOPMENT OF NOVEL DRUG PARTICLES FOR INHALATIONAL THERAPY
Find out who's winning similar federal contracts
Discover comparable awards, related contractors, and agency purchasing history.
Related intelligence
- Agency: Department of Defense
- PSC AJ11 — Product Service Code AJ11
- Federal market intelligence software